Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

Discover key insights from Roivant Sciences' Q4 2024 earnings call. Learn about their robust pipeline, pivotal 2025 milestones, and capital strength.

Immunovant stock rises on encouraging fourth-quarter fiscal 2025 results. It is on track to initiate 10 studies on IMVT-1402 across various autoimmune indications.

Shares of Immunovant, Inc. (IMVT) traded 2% higher on Thursday morning after the company reported a narrower-than-expected ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG ... gMG is a rare and chronic neuromuscular disease that causes severe muscle weakness ...

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG ... and neuromuscular disease. Zilbrysq (zilucoplan), billed ...

What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

Heart disease refers to any problem affecting the heart, such as coronary artery disease, arrhythmia, and heart failure. Symptoms and treatments depend on the type of heart disease someone has.

Film and television journalist specializing in genre for Gizmodo's pop culture vertical io9. Theme park, immersive experiences and haunt insider. Geek-core lifestyle and travel writer. Featured ...

[248] TSH receptor autoantibodies (TRAb) are heterogeneous and may either mimic the action of TSH and cause hyperthyroidism as observed in Graves' disease or alternatively, antagonize the action ...